{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:26:08Z","timestamp":1791116768587,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00702-010-0430-7","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T13:46:37Z","timestamp":1276091197000},"page":"1001-1008","source":"Crossref","is-referenced-by-count":156,"title":["Neuroinflammation in Huntington\u2019s disease"],"prefix":"10.1007","volume":"117","author":[{"given":"Thomas","family":"M\u00f6ller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"430_CR2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1471-4159.2009.05893.x","volume":"109","author":"L Amori","year":"2009","unstructured":"Amori L, Guidetti P, Pellicciari R, Kajii Y, Schwarcz R (2009) On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo. J Neurochem 109:316\u2013325","journal-title":"J Neurochem"},{"key":"430_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ng1095-115","volume":"11","author":"MA Andrade","year":"1995","unstructured":"Andrade MA, Bork P (1995) HEAT repeats in the Huntington\u2019s disease protein. Nat Genet 11:115\u2013116","journal-title":"Nat Genet"},{"key":"430_CR4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4:398\u2013403","journal-title":"Nat Genet"},{"key":"430_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","volume":"31","author":"SH Appel","year":"2010","unstructured":"Appel SH, Beers DR, Henkel JS (2010) T cell-microglial dialogue in Parkinson\u2019s disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 31:7\u201317","journal-title":"Trends Immunol"},{"key":"430_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","volume":"5","author":"MF Beal","year":"2004","unstructured":"Beal MF, Ferrante RJ (2004) Experimental therapeutics in transgenic mouse models of Huntington\u2019s disease. Nat Rev Neurosci 5:373\u2013384","journal-title":"Nat Rev Neurosci"},{"key":"430_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4020-6191-2_11","volume":"45","author":"I Bezprozvanny","year":"2007","unstructured":"Bezprozvanny I (2007) Inositol 1,4,5-tripshosphate receptor, calcium signalling and Huntington\u2019s disease. Subcell Biochem 45:323\u2013335","journal-title":"Subcell Biochem"},{"key":"430_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.molmed.2009.01.001","volume":"15","author":"I Bezprozvanny","year":"2009","unstructured":"Bezprozvanny I (2009) Calcium signaling and neurodegenerative diseases. Trends Mol Med 15:89\u2013100","journal-title":"Trends Mol Med"},{"key":"430_CR9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205:1869\u20131877","journal-title":"J Exp Med"},{"key":"430_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2004.07.012","volume":"17","author":"D Blum","year":"2004","unstructured":"Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M (2004) Clinical potential of minocycline for neurodegenerative disorders. Neurobiol Dis 17:359\u2013366","journal-title":"Neurobiol Dis"},{"key":"430_CR11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.molimm.2006.03.007","volume":"44","author":"DM Bonifati","year":"2007","unstructured":"Bonifati DM, Kishore U (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44:999\u20131010","journal-title":"Mol Immunol"},{"key":"430_CR12","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","volume":"106","author":"J Bradford","year":"2009","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S (2009) Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA 106:22480\u201322485","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR13","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","volume":"285","author":"J Bradford","year":"2010","unstructured":"Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S, Li XJ (2010) Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 285:10653\u201310661","journal-title":"J Biol Chem"},{"key":"430_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000134106","volume":"71","author":"MJ Buraczynska","year":"1995","unstructured":"Buraczynska MJ, Van Keuren ML, Buraczynska KM, Chang YS, Crombez E, Kurnit DM (1995) Construction of human embryonic cDNA libraries: HD, PKD1 and BRCA1 are transcribed widely during embryogenesis. Cytogenet Cell Genet 71:197\u2013202","journal-title":"Cytogenet Cell Genet"},{"key":"430_CR15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nurt.2007.04.006","volume":"4","author":"A Cagnin","year":"2007","unstructured":"Cagnin A, Kassiou M, Meikle SR, Banati RB (2007) Positron emission tomography imaging of neuroinflammation. Neurotherapeutics 4:443\u2013452","journal-title":"Neurotherapeutics"},{"key":"430_CR16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","volume":"5","author":"MC Carroll","year":"2004","unstructured":"Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5:981\u2013986","journal-title":"Nat Immunol"},{"key":"430_CR17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/glia.10145","volume":"40","author":"MJ Carson","year":"2002","unstructured":"Carson MJ (2002) Microglia as liaisons between the immune and central nervous system: functional implications in multiple sclerosis. Glia 40:218\u2013231","journal-title":"Glia"},{"key":"430_CR18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24:182\u2013188","journal-title":"Trends Neurosci"},{"key":"430_CR19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M (2005) Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci 6:919\u2013930","journal-title":"Nat Rev Neurosci"},{"key":"430_CR20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","volume":"83","author":"JH Cha","year":"2007","unstructured":"Cha JH (2007) Transcriptional signatures in Huntington\u2019s disease. Prog Neurobiol 83:228\u2013248","journal-title":"Prog Neurobiol"},{"key":"430_CR21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797\u2013801","journal-title":"Nat Med"},{"key":"430_CR22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng571","volume":"28","author":"AR Curtis","year":"2001","unstructured":"Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28:350\u2013354","journal-title":"Nat Genet"},{"issue":"Pt 4","key":"430_CR23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953\u20131975","journal-title":"Brain"},{"key":"430_CR24","doi-asserted-by":"crossref","unstructured":"Dinarello CA (2006) Inhibitors of histone deacetylases as anti-inflammatory drugs. Ernst Schering Res Found Workshop 56:45\u201360","DOI":"10.1007\/3-540-37673-9_3"},{"key":"430_CR25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/glia.20412","volume":"54","author":"K Farber","year":"2006","unstructured":"Farber K, Kettenmann H (2006) Functional role of calcium signals for microglial function. Glia 54:656\u2013665","journal-title":"Glia"},{"key":"430_CR26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","volume":"1792","author":"RJ Ferrante","year":"2009","unstructured":"Ferrante RJ (2009) Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim Biophys Acta 1792:506\u2013520","journal-title":"Biochim Biophys Acta"},{"key":"430_CR27","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1111\/j.1742-4658.2006.05537.x","volume":"273","author":"WJ Firdaus","year":"2006","unstructured":"Firdaus WJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, Arrigo AP (2006) Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J 273:5428\u20135441","journal-title":"FEBS J"},{"key":"430_CR28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/glia.10155","volume":"40","author":"GA Garden","year":"2002","unstructured":"Garden GA (2002) Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 40:240\u2013251","journal-title":"Glia"},{"key":"430_CR29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11481-006-9015-5","volume":"1","author":"GA Garden","year":"2006","unstructured":"Garden GA, M\u00f6ller T (2006) Microglia biology in health and disease. J Neuroimmune Pharmacol 1:127\u2013137","journal-title":"J Neuroimmune Pharmacol"},{"key":"430_CR30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","volume":"59","author":"JM Gil","year":"2009","unstructured":"Gil JM, Rego AC (2009) The R6 lines of transgenic mice: a model for screening new therapies for Huntington\u2019s disease. Brain Res Rev 59:410\u2013431","journal-title":"Brain Res Rev"},{"key":"430_CR31","unstructured":"Giorgini F (2008) The kynurenine pathway and microglia: implications for pathology and therapy in Huntington\u2019s disease. In: Outerio TF (ed) Proteinmisfolding in biology and disease. Transworld Research Network, Kerala, pp 231\u2013255"},{"key":"430_CR32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2005","unstructured":"Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ (2005) A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 37:526\u2013531","journal-title":"Nat Genet"},{"key":"430_CR33","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1074\/jbc.M708192200","volume":"283","author":"F Giorgini","year":"2008","unstructured":"Giorgini F, Moller T, Kwan W, Zwilling D, Wacker JL, Hong S, Tsai LC, Cheah CS, Schwarcz R, Guidetti P, Muchowski PJ (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J Biol Chem 283:7390\u20137400","journal-title":"J Biol Chem"},{"key":"430_CR34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","volume":"15","author":"H Goehler","year":"2004","unstructured":"Goehler H et al (2004) A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington\u2019s disease. Mol cell 15:853\u2013865","journal-title":"Mol cell"},{"key":"430_CR35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/NEN.0b013e3181996688","volume":"68","author":"MR Griffiths","year":"2009","unstructured":"Griffiths MR, Gasque P, Neal JW (2009) The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol 68:217\u2013226","journal-title":"J Neuropathol Exp Neurol"},{"key":"430_CR36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","volume":"46","author":"X Gu","year":"2005","unstructured":"Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I, Heintz N, Yang XW (2005) Pathological cell\u2013cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 46:433\u2013444","journal-title":"Neuron"},{"key":"430_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-2-8","volume":"2","author":"X Gu","year":"2007","unstructured":"Gu X, Andre VM, Cepeda C, Li SH, Li XJ, Levine MS, Yang XW (2007) Pathological cell\u2013cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington\u2019s disease. Mol neurodegener 2:8","journal-title":"Mol neurodegener"},{"key":"430_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ (2003) Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 527:105\u2013112","journal-title":"Adv Exp Med Biol"},{"key":"430_CR39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/35039051","volume":"1","author":"JF Gusella","year":"2000","unstructured":"Gusella JF, MacDonald ME (2000) Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci 1:109\u2013115","journal-title":"Nat Rev Neurosci"},{"key":"430_CR40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tibs.2006.06.009","volume":"31","author":"JF Gusella","year":"2006","unstructured":"Gusella JF, Macdonald ME (2006) Huntington\u2019s disease: seeing the pathogenic process through a genetic lens. Trends Biochem Sci 31:533\u2013540","journal-title":"Trends Biochem Sci"},{"key":"430_CR41","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","volume":"10","author":"UK Hanisch","year":"2007","unstructured":"Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387\u20131394","journal-title":"Nat Neurosci"},{"key":"430_CR42","unstructured":"Hanisch U-K, Kohsaka S, M\u00f6ller T (eds) (2002) Special issue microglia. Wiely-Liss, New York"},{"key":"430_CR43","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1517\/17425255.4.10.1265","volume":"4","author":"GJ Harry","year":"2008","unstructured":"Harry GJ, Kraft AD (2008) Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol 4:1265\u20131277","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"430_CR44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.brainresrev.2004.12.012","volume":"48","author":"M Hauwel","year":"2005","unstructured":"Hauwel M, Furon E, Canova C, Griffiths M, Neal J, Gasque P (2005) Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, \u201cprotective\u201d glial stem cells and stromal ependymal cells. Brain Res Brain Res Rev 48:220\u2013233","journal-title":"Brain Res Brain Res Rev"},{"key":"430_CR45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"HDCR Group","year":"1993","unstructured":"HDCR Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"430_CR46","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","volume":"1","author":"SM Hersch","year":"2004","unstructured":"Hersch SM, Ferrante RJ (2004) Translating therapies for Huntington\u2019s disease from genetic animal models to clinical trials. NeuroRx 1:298\u2013306","journal-title":"NeuroRx"},{"key":"430_CR47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/157488906775245273","volume":"1","author":"L Hertz","year":"2006","unstructured":"Hertz L, Zhao Z, Chen Y (2006) The astrocytic GABA(A)\/benzodiazepine-like receptor: the Joker receptor for benzodiazepine-mimetic drugs? Recent Pat CNS Drug Discov 1:93\u2013103","journal-title":"Recent Pat CNS Drug Discov"},{"key":"430_CR48","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","volume":"9","author":"P Hilditch-Maguire","year":"2000","unstructured":"Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, MacDonald ME (2000) Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9:2789\u20132797","journal-title":"Hum Mol Genet"},{"key":"430_CR49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8:382\u2013397","journal-title":"Lancet Neurol"},{"key":"430_CR50","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","volume":"100","author":"E Hockly","year":"2003","unstructured":"Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PA, Steffan JS, Marsh JL, Thompson LM, Lewis CM, Marks PA, Bates GP (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease. Proc Natl Acad Sci USA 100:2041\u20132046","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR51","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1523\/JNEUROSCI.23-11-04410.2003","volume":"23","author":"A Hoffmann","year":"2003","unstructured":"Hoffmann A, Kann O, Ohlemeyer C, Hanisch UK, Kettenmann H (2003) Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. J Neurosci 23:4410\u20134419","journal-title":"J Neurosci"},{"key":"430_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)13074-3","volume":"18","author":"SH Im","year":"2004","unstructured":"Im SH, Rao A (2004) Activation and deactivation of gene expression by Ca2+\/calcineurin-NFAT-mediated signaling. Mol Cells 18:1\u20139","journal-title":"Mol Cells"},{"key":"430_CR53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","volume":"412","author":"S Imarisio","year":"2008","unstructured":"Imarisio S, Carmichael J, Korolchuk V, Chen CW, Saiki S, Rose C, Krishna G, Davies JE, Ttofi E, Underwood BR, Rubinsztein DC (2008) Huntington\u2019s disease: from pathology and genetics to potential therapies. Biochem J 412:191\u2013209","journal-title":"Biochem J"},{"key":"430_CR54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","volume":"38","author":"YS Kim","year":"2006","unstructured":"Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson\u2019s disease. Exp Mol Med 38:333\u2013347","journal-title":"Exp Mol Med"},{"key":"430_CR55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","volume":"196","author":"HS Kim","year":"2009","unstructured":"Kim HS, Suh YH (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196:168\u2013179","journal-title":"Behav Brain Res"},{"key":"430_CR56","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","volume":"321","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321:892\u2013901","journal-title":"J Pharmacol Exp Ther"},{"key":"430_CR1","doi-asserted-by":"crossref","unstructured":"Kuhn A et al (2007) Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16:1845\u20131861","DOI":"10.1093\/hmg\/ddm133"},{"key":"430_CR57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","volume":"20","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ (2004) Huntingtin\u2013protein interactions and the pathogenesis of Huntington\u2019s disease. Trends Genet 20:146\u2013154","journal-title":"Trends Genet"},{"key":"430_CR58","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0896-6273(93)90127-D","volume":"11","author":"SH Li","year":"1993","unstructured":"Li SH, Schilling G, Young WS 3rd, Li XJ, Margolis RL, Stine OC, Wagster MV, Abbott MH, Franz ML, Ranen NG et al (1993) Huntington\u2019s disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11:985\u2013993","journal-title":"Neuron"},{"key":"430_CR59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10:137\u2013144","journal-title":"Hum Mol Genet"},{"key":"430_CR60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","volume":"10","author":"CS Lobsiger","year":"2007","unstructured":"Lobsiger CS, Cleveland DW (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10:1355\u20131360","journal-title":"Nat Neurosci"},{"key":"430_CR61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493\u2013506","journal-title":"Cell"},{"key":"430_CR62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1385\/NMM:9:1:47","volume":"9","author":"S Mievis","year":"2007","unstructured":"Mievis S, Levivier M, Communi D, Vassart G, Brotchi J, Ledent C, Blum D (2007) Lack of minocycline efficiency in genetic models of Huntington\u2019s disease. Neuromolecular Med 9:47\u201354","journal-title":"Neuromolecular Med"},{"key":"430_CR63","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/glia.10152","volume":"40","author":"T M\u00f6ller","year":"2002","unstructured":"M\u00f6ller T (2002) Calcium signaling in microglial cells. Glia 40:184\u2013194","journal-title":"Glia"},{"key":"430_CR64","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1523\/JNEUROSCI.17-02-00615.1997","volume":"17","author":"T M\u00f6ller","year":"1997","unstructured":"M\u00f6ller T, Nolte C, Burger R, Verkhratsky A, Kettenmann H (1997) Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia. J Neurosci 17:615\u2013624","journal-title":"J Neurosci"},{"key":"430_CR65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(99)00196-X","volume":"375","author":"F Moroni","year":"1999","unstructured":"Moroni F (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol 375:87\u2013100","journal-title":"Eur J Pharmacol"},{"key":"430_CR66","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0306-4522(96)00106-6","volume":"73","author":"C Nolte","year":"1996","unstructured":"Nolte C, Moller T, Walter T, Kettenmann H (1996) Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience 73:1091\u20131107","journal-title":"Neuroscience"},{"key":"430_CR67","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","volume":"30","author":"HT Orr","year":"2007","unstructured":"Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575\u2013621","journal-title":"Annu Rev Neurosci"},{"key":"430_CR68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/187152709788680689","volume":"8","author":"D Orsucci","year":"2009","unstructured":"Orsucci D, Calsolaro V, Mancuso M, Siciliano G (2009) Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol Disord Drug Targets 8:222\u2013231","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"430_CR69","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, Sagredo O, Benito C, Romero J, Azcoitia I, Fernandez-Ruiz J, Guzman M, Galve-Roperh I (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington\u2019s disease excitotoxicity. Brain 132:3152\u20133164","journal-title":"Brain"},{"key":"430_CR70","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"430_CR71","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638\u20131643","journal-title":"Neurology"},{"key":"430_CR72","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0072-9752(07)83026-0","volume":"83","author":"S Przedborski","year":"2007","unstructured":"Przedborski S (2007) Neuroinflammation and Parkinson\u2019s disease. Handb Clin Neurol 83:535\u2013551","journal-title":"Handb Clin Neurol"},{"key":"430_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00424-004-1364-4","volume":"450","author":"A Quintana","year":"2005","unstructured":"Quintana A, Griesemer D, Schwarz EC, Hoth M (2005) Calcium-dependent activation of T-lymphocytes. Pflugers Arch 450:1\u201312","journal-title":"Pflugers Arch"},{"key":"430_CR74","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","volume":"27","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119\u2013145","journal-title":"Annu Rev Immunol"},{"key":"430_CR75","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1902\/jop.2008.080171","volume":"79","author":"J Rogers","year":"2008","unstructured":"Rogers J (2008) The inflammatory response in Alzheimer\u2019s disease. J Periodontol 79:1535\u20131543","journal-title":"J Periodontol"},{"key":"430_CR76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/WCO.0b013e328304b692","volume":"21","author":"E Roze","year":"2008","unstructured":"Roze E, Saudou F, Caboche J (2008) Pathophysiology of Huntington\u2019s disease: from huntingtin functions to potential treatments. Curr Opin Neurol 21:497\u2013503","journal-title":"Curr Opin Neurol"},{"key":"430_CR106","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K, Bhide PG, Vonsattel JP, DiFiglia M (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60:161\u2013172","journal-title":"J Neuropathol Exp Neurol"},{"key":"430_CR77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","volume":"4","author":"R Schwarcz","year":"2004","unstructured":"Schwarcz R (2004) The kynurenine pathway of tryptophan degradation as a drug target. Curr Opin Pharmacol 4:12\u201317","journal-title":"Curr Opin Pharmacol"},{"key":"430_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","volume":"303","author":"R Schwarcz","year":"2002","unstructured":"Schwarcz R, Pellicciari R (2002) Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1\u201310","journal-title":"J Pharmacol Exp Ther"},{"key":"430_CR79","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","volume":"219","author":"R Schwarcz","year":"1983","unstructured":"Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316\u2013318","journal-title":"Science"},{"key":"430_CR80","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ (2010) Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease. Prog Neurobiol 90:230\u2013245","journal-title":"Prog Neurobiol"},{"key":"430_CR81","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","volume":"171","author":"JY Shin","year":"2005","unstructured":"Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171:1001\u20131012","journal-title":"J Cell Biol"},{"key":"430_CR82","first-page":"743","volume":"46","author":"S Shoham","year":"2000","unstructured":"Shoham S, Youdim MB (2000) Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases. Cell Mol Biol (Noisy-le-Grand, France) 46:743\u2013760","journal-title":"Cell Mol Biol (Noisy-le-Grand, France)"},{"key":"430_CR83","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","volume":"20","author":"A Silvestroni","year":"2009","unstructured":"Silvestroni A, Faull RL, Strand AD, Moller T (2009) Distinct neuroinflammatory profile in post-mortem human Huntington\u2019s disease. Neuroreport 20:1098\u20131103","journal-title":"Neuroreport"},{"key":"430_CR84","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons DA, Casale M, Alcon B, Pham N, Narayan N, Lynch G (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease. Glia 55:1074\u20131084","journal-title":"Glia"},{"key":"430_CR85","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","volume":"159","author":"SK Singhrao","year":"1999","unstructured":"Singhrao SK, Neal JW, Morgan BP, Gasque P (1999) Increased complement biosynthesis by microglia and complement activation on neurons in Huntington\u2019s disease. Exp Neurol 159:362\u2013376","journal-title":"Exp Neurol"},{"key":"430_CR86","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567","journal-title":"Hum Mol Genet"},{"key":"430_CR87","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng0893-393","volume":"4","author":"RG Snell","year":"1993","unstructured":"Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou LP, Davies P, MacDonald ME, Gusella JF, Harper PS, Shaw DJ (1993) Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington\u2019s disease. Nat Genet 4:393\u2013397","journal-title":"Nat Genet"},{"key":"430_CR88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","volume":"1762","author":"EC Stack","year":"2006","unstructured":"Stack EC, Smith KM, Ryu H, Cormier K, Chen M, Hagerty SW, Del Signore SJ, Cudkowicz ME, Friedlander RM, Ferrante RJ (2006) Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington\u2019s disease mice. Biochim Biophys Acta 1762:373\u2013380","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 1","key":"430_CR89","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","volume":"56","author":"N Stella","year":"2009","unstructured":"Stella N (2009) Endocannabinoid signaling in microglial cells. Neuropharmacology 56(Suppl 1):244\u2013253","journal-title":"Neuropharmacology"},{"key":"430_CR90","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainresrev.2004.12.013","volume":"48","author":"WJ Streit","year":"2005","unstructured":"Streit WJ (2005) Microglia and neuroprotection: implications for Alzheimer\u2019s disease. Brain Res Brain Res Rev 48:234\u2013239","journal-title":"Brain Res Brain Res Rev"},{"key":"430_CR91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/187152809789352249","volume":"8","author":"S Sugama","year":"2009","unstructured":"Sugama S, Takenouchi T, Cho BP, Joh TH, Hashimoto M, Kitani H (2009) Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm Allergy Drug Targets 8:277\u2013284","journal-title":"Inflamm Allergy Drug Targets"},{"key":"430_CR92","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","volume":"72","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P (2007a) Imaging microglial activation in Huntington\u2019s disease. Brain Res Bull 72:148\u2013151","journal-title":"Brain Res Bull"},{"key":"430_CR93","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P (2007b) Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130:1759\u20131766","journal-title":"Brain"},{"key":"430_CR94","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"TS Tang","year":"2005","unstructured":"Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease. Proc Natl Acad Sci USA 102:2602\u20132607","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR95","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10534-005-3710-1","volume":"18","author":"I Theurl","year":"2005","unstructured":"Theurl I, Fritsche G, Ludwiczek S, Garimorth K, Bellmann-Weiler R, Weiss G (2005) The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals 18:359\u2013367","journal-title":"Biometals"},{"key":"430_CR96","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas EA, Coppola G, Desplats PA, Tang B, Soragni E, Burnett R, Gao F, Fitzgerald KM, Borok JF, Herman D, Geschwind DH, Gottesfeld JM (2008) The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice. Proc Natl Acad Sci USA 105:15564\u201315569","journal-title":"Proc Natl Acad Sci USA"},{"key":"430_CR97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","volume":"10","author":"Y Trottier","year":"1995","unstructured":"Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL (1995) Cellular localization of the Huntington\u2019s disease protein and discrimination of the normal and mutated form. Nat Genet 10:104\u2013110","journal-title":"Nat Genet"},{"key":"430_CR98","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/B:MEBR.0000043984.73063.d8","volume":"19","author":"D Rossum van","year":"2004","unstructured":"van Rossum D, Hanisch UK (2004) Microglia. Metab Brain Dis 19:393\u2013411","journal-title":"Metab Brain Dis"},{"key":"430_CR99","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"430_CR100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"430_CR101","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","volume":"27","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Semin Neurol 27:143\u2013150","journal-title":"Semin Neurol"},{"key":"430_CR102","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/fnl.10.1","volume":"5","author":"JR Weinstein","year":"2010","unstructured":"Weinstein JR, Koerner IP, M\u00f6ller T (2010) Microglia in ischemic brain injury. Future Neurol 5:227\u2013246","journal-title":"Future Neurol"},{"key":"430_CR103","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pmr.2005.08.021","volume":"16","author":"P Weydt","year":"2005","unstructured":"Weydt P, M\u00f6ller T (2005) The role of microglial cells in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 16:1081\u20131090 (xi)","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"430_CR104","first-page":"1005","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005\u20131015","journal-title":"Nat Med"},{"key":"430_CR105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/glia.20416","volume":"54","author":"X Zhang","year":"2006","unstructured":"Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54:795\u2013804","journal-title":"Glia"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0430-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-010-0430-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0430-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:26:45Z","timestamp":1711542405000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0430-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["430"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0430-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,10]]}}}